Brief: NextCure Reports Q4 2020 Financial Results
04/03/2021 22:39
March 4 (Reuters) - NextCure Inc NXTC.O :
* NEXTCURE INC QTRLY NET LOSS $15.5 MILLION VERSUS $10.9
MILLION
* NEXTCURE - EXPECTS EXISTING CASH, CASH EQUIVALENTS &
MARKETABLE
SECURITIES TO ENABLE FUND OPERATING EXPENSES & CAPITAL
EXPENDITURE INTO H2 OF 2023
Source text for Eikon: ID:nGNX89HHvp
Further company coverage: NXTC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NextCure
See all newsBrief: Xcellon Biologics Co Acquires Gmp Manufacturing Facility From Nextcure
NextCure Inc reports results for the quarter ended June 30 - Earnings Summary
NextCure Q2 net loss narrows on lower expenses
Brief: NextCure Q2 Net Income USD -14.892 Million
NextCure Inc expected to post a loss of $1.93 a share - Earnings Preview